Atlas Trials

Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients

Clinical trial NCT05445024 · UNKNOWN

Trial details

NCT number
NCT05445024
Sponsor
Qianfoshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
LaparoscopicGastrointestinal Surgery
Start date
2023-01-01
Primary completion
2023-11-30
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.